Wyoming was one of the first states to enact a law to allow out-of-state regulated insurers to sell insurance products domestically, in an attempt to increase competition and decrease the cost of entering the new market. Although Wyoming has made limited strides in health care cost transparency, the Wyoming Hospital Association has attempted to fill in the gap by offering a price disclosure database for its hospitals online. A coalition of Wyoming employers is also interested in obtaining charge data across all insured in order to better negotiate rates directly with providers.
In the 2019 legislative session, the Wyoming legislature introduced several legislation designed to address rising prescription drug prices, including drug importation (HB 287) and the Wyoming Health Care Pricing Transparency Act (HB 292), which requires insurers to provide health claims data to group purchasers of private health benefit plans. While neither of these measures passed, the state did enact HB 63, joining other states to prohibit PBMs from penalizing the disclosure of prescription cost information or affordable alternatives.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare.
LEGISLATION: The Database of State Laws Impacting Healthcare Cost and Quality (SLIHCQ), created by The Source on Healthcare Price & Competition and Catalyst for Payment Reform, catalogues state legislation governing price transparency, provider market power, provider payment, provider networks, and benefit design. The database also includes pharmaceutical legislation beginning in the 2017-2018 legislative session. *Note: Current legislative session bill updates are ongoing. Check back weekly for updates.
LITIGATION: The Source tracks major litigation and antitrust enforcement action by federal entities (FTC or DOJ), state attorney generals, and private parties in the main provider and insurer markets, particularly legal challenges of healthcare consolidation and anticompetitive contract provisions. Additionally, the database contains major pharmaceutical cases including legislation challenges and significant appellate cases.
Search the database across all jurisdictions on the State Overview page, or view and filter existing legislation or litigation on individual state pages. The database allows customized search and filter by keyword, status, and/or key issue category. *Multiple filter/selections enabled. Click here for User Guide.